Last Week Of Fun In The Markets? Click to watch.

$2.77 (-1.42%)

Volume: 653.948k

Closed: Jun 30, 2022

Hollow Logo Score: -1.916

Affimed N.V. Stock Forecast

BUY SELL NASDAQ:AFMD
$2.77 (-1.42%)

Volume: 653.948k

Closed: Jun 30, 2022

Score Hollow Logo -1.916

AFMD Price Targets and Analyst Ratings NASDAQ:AFMD

Historical Ratings and Targets

Date Upside / Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
2022-06-23 224.91% SVB Leerink $10.00 $9.00 Maintains Outperform
2022-03-31 152.71% Piper Sandler $7.00 Initiates Coverage On Overweight
2022-02-23 333.21% Cantor Fitzgerald $12.00 Initiates Coverage On Overweight
2021-10-21 261.01% Truist Securities $10.00 Initiates Coverage On Buy
2021-10-12 333.21% SVB Leerink $13.00 $12.00 Maintains Outperform
2021-09-30 333.21% Stifel $12.00 Initiates Coverage On Buy
2021-03-31 441.52% Credit Suisse $15.00 Initiates Coverage On Outperform
2021-03-24 441.52% Wells Fargo $10.00 $15.00 Maintains Overweight
2021-03-11 405.42% SVB Leerink $9.00 $14.00 Maintains Outperform
2020-11-11 224.91% SVB Leerink $8.00 $9.00 Maintains Outperform
2020-06-24 188.81% SVB Leerink $7.00 $8.00 Maintains Outperform

AFMD Stock Trend

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $2.81 will firstly indicate a slower falling rate, but may be the first sign of a trend shift.

Given the current short-term trend, the stock is expected to fall -43.88% during the next 3 months and, with a 90% probability hold a price between $1.05 and $1.58 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2022-07-05 $1.84 $2.31 $2.78
2022-07-06 $1.81 $2.28 $2.74
2022-07-07 $1.77 $2.24 $2.71
2022-07-08 $1.74 $2.20 $2.67
2022-07-11 $1.70 $2.17 $2.64
2022-07-12 $1.67 $2.13 $2.60
2022-07-13 $1.63 $2.10 $2.57
2022-07-14 $1.60 $2.06 $2.53
2022-07-15 $1.56 $2.03 $2.49
2022-07-18 $1.52 $1.99 $2.46
2022-07-19 $1.49 $1.96 $2.42
2022-07-20 $1.45 $1.92 $2.39
2022-07-21 $1.42 $1.89 $2.35
2022-07-22 $1.38 $1.85 $2.32
2022-07-25 $1.35 $1.81 $2.28
2022-07-26 $1.31 $1.78 $2.25
2022-07-27 $1.28 $1.74 $2.21
2022-07-28 $1.24 $1.71 $2.17
2022-07-29 $1.21 $1.67 $2.14
2022-08-01 $1.17 $1.64 $2.10
2022-08-02 $1.13 $1.60 $2.07
2022-08-03 $1.10 $1.57 $2.03
2022-08-04 $1.06 $1.53 $2.00
2022-08-05 $1.03 $1.49 $1.96
2022-08-08 $0.99 $1.46 $1.93
2022-08-09 $0.96 $1.42 $1.89
2022-08-10 $0.92 $1.39 $1.86
2022-08-11 $0.89 $1.35 $1.82
2022-08-12 $0.85 $1.32 $1.78
2022-08-15 $0.82 $1.28 $1.75

IMPROVE YOUR TRADING GAME WITH A GOLDEN STAR

From 27 537 stocks, only a few dozen will trigger such a signal!

About Affimed N.V.

Affimed NV Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies. Its lead candidate is AFM13, a natural killer cell TandAb designed for the treatment of CD30-positive (CD30+) B- and T-cell malignancies, including Hodgkin lymphoma. The company’s product candidates also include AFM11, a T-cell TandAb, which is in Phase I clinical trial for the treatment of various CD19+ B-cell malignancies, in... Read more

.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT